Searching for Solutions

Improve your peer review skills! Discover the components to evaluate, the role of the peer reviewer, the skills necessary to critically evaluate a manuscript, and how to provide feedback to authors and journal editors.

Antipsychotic prescriptions for older adults in the U.S. have increased in the last decade, especially from long-term care pharmacies. That’s according to a study published in JAMA Psychiatry, which found that among adults aged 65 and older, rates of antipsychotic use increased from 2.67 per 100 people in 2015 to 4.05 per 100 in 2024. Researchers analyzed a decade of antipsychotic prescription claims from around the country for more than 8 million people aged 65 or older. Long-term use increased over the years, as did prescriptions from long-term care pharmacies. Prescriptions from psychiatrists declined. The patterns suggest an increase in chronic conditions or cognitive impairments among older adults, the authors write. They believe the increase in prescriptions emphasize the importance of improving mental health care and behavioral interventions for this population.

As I look back on this year for the American Association of Psychiatric Pharmacists (AAPP), I am deeply grateful for the achievements that have strengthened our association and advanced our shared mission.

Dr. Jerry McKee, PharmD, MS, BCPP, explains the difference between BCPP re-testing versus recertification.

A one-time gift of $5,000 or more can sustain major grant programs that directly advance psychiatric pharmacy practice. These programs expand services, prove clinical impact, and support emerging leaders. Consider making a meaningful investment in your profession. #AAPPFoundation #AdvancingPsychPharmacy

AAPP and the AAPP Foundation are pleased to be offering a complimentary, 2-hour workshop: Cultivating Expertise: Enhancing Presentation Design and Speaker Development in Psychiatric Pharmacists. Earn ACPE credit and make yourself a standout voice in the field of psychiatric pharmacy!

This free pharmacist toolkit provides clinicians with evidence-based information necessary to safely and confidently manage patients who are candidates for treatment with MAOIs.